Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? - Wikidata - wikimedia - TriplyDB

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

http://www.wikidata.org/entity/Q35116303

about

Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes Expanding the clinical indications for α(1)-antitrypsin therapy Experimental Diabetes Mellitus in Different Animal Models Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy.Immunotherapeutic strategies in autoimmune uveitis Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes.Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.Novel autoantigens in type 1 diabetes.It's time to bring dendritic cell therapy to type 1 diabetes.Restoring insulin production for type 1 diabetes.Role of immune system modulation in prevention of type 1 diabetes mellitus.Eulogy for the Metabolic Clinical Investigator?

P2860

Q26861561-DBDDA4E0-0B9C-4B35-987E-7911F3EEAE6F Q27000764-8C6853B7-1ACC-4365-8284-53A7531C5ED9 Q28066824-DA8B8642-8B49-4FEC-9DC9-DEF5FB989A2B Q28548359-C7FB0278-EF58-498E-9550-C7D0591EACEB Q33413423-35979844-449A-4560-ADFA-9C46A85EB20A Q34274950-ED12048E-1DAC-4C47-B979-AF3BE9C80B36 Q35261125-68235D28-927D-4139-B3D7-E26AFCE5721E Q35902870-49C36626-C97B-4251-9125-75E5630E046D Q35949475-8647CF86-9A19-43BD-B337-115661AC8D2C Q36881807-35E75516-B6E3-4EF5-85C5-9EA1326206CB Q37670174-620F1848-8B4C-4B96-BF20-2A8BAE831144 Q37994917-A743A665-0CF1-4851-8D71-FCDDA87226F0 Q39505919-59AFB8C6-0A88-4B19-A364-0CC8A44C0CE6 Q42392159-5EF19B1B-796C-4A76-B56A-78DF8F68336A

P2860

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

http://www.wikidata.org/entity/Q35116303

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Current state of type 1 diabet ...... ge leaps, or more of the same?

@ast

Current state of type 1 diabet ...... ge leaps, or more of the same?

@en

type

label

Current state of type 1 diabet ...... ge leaps, or more of the same?

@ast

Current state of type 1 diabet ...... ge leaps, or more of the same?

@en

prefLabel

Current state of type 1 diabet ...... ge leaps, or more of the same?

@ast

Current state of type 1 diabet ...... ge leaps, or more of the same?

@en

P1433

Q35116303-474B9EAC-0707-44B5-B40C-E1F05958117C

P1476

Q35116303-07328F06-9BB5-4ED3-B1C5-66DAD6D32311

P2093

Q35116303-1A7AA018-A567-4B05-ABBA-D9D7A3803FFF

Q35116303-4ACC924B-BBD6-4E77-8485-7E1DB243E0F1

Q35116303-4C517DB7-83E4-4192-964B-47DB21EC4885

P275

Q35116303-9DDC5A6E-453B-459A-8FCB-53765CAC3B7D

P2860

Q35116303-00874198-B152-42C3-A1C2-F343DEFE609E

Q35116303-01404588-0234-463C-9F25-041115621F48

Q35116303-04269247-DC14-4474-AF37-A4D1AF8A248F

Q35116303-04F47326-67FE-4FCC-BA69-6E16297BBC79

Q35116303-08E93876-FF07-4387-91B9-A37541C5C414

Q35116303-09F41F93-61A0-4CCC-84CE-F1A276962758

Q35116303-0A570207-F0BE-496E-9B25-AC04869478E4

Q35116303-0B1AC441-7DF4-480E-B32C-6C0DF871EC30

Q35116303-0C52F531-97EB-451D-B00D-BCD2D0672B7D

Q35116303-0E09F38F-1DB1-4927-ACCA-6C08A850C77C

P304

Q35116303-BF83BE92-689D-457C-BDC7-509F5867498A

P31

Q35116303-664ED27F-1EFB-40EC-8A57-E05C27F14DAC

Q35116303-B696D090-E6D2-4635-B06D-1E3A25939698

P356

Q35116303-E3AFA14E-02D8-4C12-9174-8E4F74816CF5

P478

Q35116303-31C74573-9C1D-4841-ADD8-101340B4DF2B

P5008

Q35116303-12A00757-7818-48AD-BF8A-A579042C4A87

P577

Q35116303-8F6C1C4C-3F65-4857-ADA9-06E02C47047D

P5875

Q35116303-0E2F45B9-7221-4283-9580-280393D2057C

P698

Q35116303-7C0B9679-1F8F-4EB6-AC85-67A50AC0E7E5

P921

Q35116303-14CECC5B-1710-4644-9A44-0EB957AEA31C

Q35116303-39B25B0E-75D5-4403-80BE-0E3C09D877F7

Q35116303-629E44B0-D024-462E-B585-F02B422B2924

Q35116303-918591B9-1E81-49E2-A4E6-683AE6669BCD

Q35116303-99D58C17-D9CA-472A-85A9-1E1B96C2E4C6

Q35116303-B2F616B7-5D6D-4A66-BE7E-A3041CF8D964

Q35116303-CE57B3A6-48A4-4118-B9B2-F44BE1D05022

Q35116303-FCE3F2DD-6F18-4D60-B710-AC0D1DF3B9C9

P932

Q35116303-B0002599-5F3C-4D10-8C66-2EDD33EF3458

P356

P1433

Clinical and Developmental Immunology

P1476

Current state of type 1 diabet ...... ge leaps, or more of the same?

@en

P2093

Brett Phillips

http://www.w3.org/2001/XMLSchema#string

Massimo Trucco

http://www.w3.org/2001/XMLSchema#string

Nick Giannoukakis

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Diagnosis and Classification of Diabetes Mellitus

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells

Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

P304

432016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/432016

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51517896

http://www.w3.org/2001/XMLSchema#string

P698

21785616

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

monoclonal antibody

biomedical investigative technique

hemic and immune systems

P932

3139873

http://www.w3.org/2001/XMLSchema#string